Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling | PLOS Computational Biology
![A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/592dc2d8-d9c8-44c8-b3e0-18b7bb3be1c6/gr1_lrg.jpg)
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine
![A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-61535-9/MediaObjects/41598_2020_61535_Fig1_HTML.png)
A new clinical-genomic model to predict 10-year recurrence risk in primary operable breast cancer patients | Scientific Reports
![Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age | Breast Cancer Research | Full Text Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-020-01327-1/MediaObjects/13058_2020_1327_Fig1_HTML.png)
Discordance in 21-gene recurrence scores between paired breast cancer samples is inversely associated with patient age | Breast Cancer Research | Full Text
![EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post](https://ascopost.com/media/14002242/71304_table-1.jpg)
EBCTCG Analysis Identifies Recurrence Risk by Tumor Subgroup in Estrogen Receptor–Positive Breast Cancer - The ASCO Post
![Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation - ScienceDirect Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0360301620311214-gr1.jpg)
Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation - ScienceDirect
![Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs - Value in Health Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs - Value in Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a95008fc-3c85-4126-a926-5d2b7c680158/gr3_lrg.jpg)
Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs - Value in Health
![The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-57094-3/MediaObjects/41598_2019_57094_Fig1_HTML.png)
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer | Scientific Reports
![Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations | British Journal of Cancer Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-0937-0/MediaObjects/41416_2020_937_Fig1_HTML.png)